Center for Scientific Review; Notice of Closed Meetings, 65363-65364 [2016-22815]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 184 / Thursday, September 22, 2016 / Notices
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892–9529, 301–496–0660,
webbere@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke Initial
Review Group; Neurological Sciences and
Disorders B.
Date: October 27–28, 2016.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel and Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892–9529, 301–496–0288,
neuhuber@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: September 16, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–22814 Filed 9–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Immunopathology and
Immunotherapy.
Date: October 6, 2016.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M. Quadri, Ph.D.,
Scientific Review Officer, Center for
VerDate Sep<11>2014
18:58 Sep 21, 2016
Jkt 238001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory Processes.
Date: October 11–12, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group:
Hemostasis and Thrombosis Study Section.
Date: October 20, 2016.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Bukhtiar H. Shah, DVM,
Ph.D., Scientific Review Officer, Vascular
and Hematology IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4120, MSC 7802,
Bethesda, MD 20892, (301) 806–7314,
shahb@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group: Language and Communication Study
Section.
Date: October 20–21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Wind Cowles, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
Bethesda, MD 20892, cowleshw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel: Ocular
Surface, Cornea, and Refractive Error.
Date: October 20, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 2620 Hotel, 2620 Jones Street,
San Francisco, CA 94133.
Contact Person: Kristin Kramer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5205,
MSC 7846, Bethesda, MD 20892, (301) 437–
0911, kramerkm@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 20–21, 2016.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
65363
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW., Washington, DC 20036.
Contact Person: Guangyong Ji, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—A Study Section.
Date: October 20–21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria, 1900
Diagonal Road, Alexandria, VA 22314.
Contact Person: Kenneth M. Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204,
MSC 7808, Bethesda, MD 20892, 301–496–
6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurobiology of Epilepsy, Spinal
Cord Injury, and Protein, Processing in
Neurodegeneration.
Date: October 20, 2016.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1236, zhaow@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Child Psychopathology and
Developmental Disabilities Study Section.
Date: October 20–21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jane A. DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Pathogenic Eukaryotes Study Section.
Date: October 20–21, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Washington DC
Downtown, 1199 Vermont Avenue NW.,
Washington, DC 20005.
Contact Person: Tera Bounds, DVM, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, 301–435–
2306, boundst@csr.nih.gov.
E:\FR\FM\22SEN1.SGM
22SEN1
65364
Federal Register / Vol. 81, No. 184 / Thursday, September 22, 2016 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug
Discovery and Mechanisms of Antimicrobial
Resistance.
Date: October 20, 2016.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW., Washington, DC 20036.
Contact Person: John C. Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Language
and Communication.
Date: October 20, 2016.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Palomar Hotel, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Maribeth Champoux,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7759, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 16, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–22815 Filed 9–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 16, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2016–22817 Filed 9–21–16; 8:45 am]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will also be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov).
VerDate Sep<11>2014
18:58 Sep 21, 2016
Jkt 238001
Name of Committee: Board of Scientific
Advisors.
Open: October 31, 2016, 1:00 p.m. to 4:00
p.m.
Agenda: RFA and RFP Concept Reviews.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
TE406, Rockville, MD 20850 (Virtual
Meeting).
Contact Person: Paulette S. Gray, Ph.D.,
Executive Secretary, Division of Extramural
Activities, National Cancer Institute—Shady
Grove, National Institutes of Health, 9609
Medical Center Drive, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NCI Shady Grove
has instituted stringent procedures for
entrance into the NCI Shady Grove building.
Visitors will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive Patent
License: Development of an AntibodyDrug Conjugate for Use in
PhotoImmunoTherapy
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an exclusive patent license to
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
practice the inventions embodied in the
U.S. Patents and Patent Applications
listed in the Summary Information
section of this notice to Aspyrian
Therapeutics, Inc. (‘‘Aspyrian’’) located
in San Diego, California USA.
DATES: Only written comments and/or
applications for a license which are
received by the National Cancer
Institute’s Technology Transfer Center
on or before October 7, 2016 will be
considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, and
comments relating to the contemplated
exclusive license should be directed to:
Thomas Clouse, J.D., Senior Licensing
and Patenting Manager, NCI Technology
Transfer Center, 9609 Medical Center
Drive, RM 1E530 MSC 9702, Bethesda,
MD 20892–9702 (for business mail),
Rockville, MD 20850–9702 Telephone:
(240)–276–5530; Facsimile: (240)–276–
5504 Email: thomas.clouse@nih.gov.
SUPPLEMENTARY INFORMATION:
Intellectual Property
United States Provisional Patent
Application No. 62/202,252, filed
August 7, 2015 ‘‘Near Infrared
PhotoImmunoTherapy (NIR–PIT) of
Suppressor Cells to Treat Cancer’’ [HHS
Reference No. E–231–2015/0–US–01];
and
PCT Patent Application PCT/US2016/
045090, filed August 2, 2016 ‘‘Near
Infrared PhotoImmunoTherapy (NIR–
PIT) of Suppressor Cells to Treat
Cancer’’ [HHS Reference No. E–231–
2015/0–PCT–02].
The patent rights in these inventions
have been assigned and/or exclusively
licensed to the government of the
United States of America.
The prospective exclusive license
territory may be worldwide and the
field of use may be limited to the use
of Licensed Patent Rights for the
following: ‘‘Use of photosensitizing
antibody-fluorophore conjugate defined
by the Licensed Patent Rights by itself
for PhotoImmunoTherapy (PIT), or in
combination with cancer therapeutic
agents, to treat cancer or hyperplasia.’’
This technology discloses the concept
of binding an anti-foxp3+ antibody to
IR700 to bind to foxp3+ T-cells. When
irradiated with near infrared light
localized at the site of the solid tumor,
controlled local knockdown of foxp3+
negative regulatory T-cells in tumors
results in rapid tumor death without the
severe autoimmune response that is
induced by systemic knock-down of
foxp3+ T-cells. Theoretically, this
technology can be used in a broad
spectrum of patients with a variety of
solid cancers including those with
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 81, Number 184 (Thursday, September 22, 2016)]
[Notices]
[Pages 65363-65364]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22815]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Immunopathology and Immunotherapy.
Date: October 6, 2016.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Syed M. Quadri, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD
20892, 301-435-1211, quadris@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Auditory Processes.
Date: October 11-12, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
Name of Committee: Vascular and Hematology Integrated Review
Group: Hemostasis and Thrombosis Study Section.
Date: October 20, 2016.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review
Officer, Vascular and Hematology IRG, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge Drive, Room 4120, MSC
7802, Bethesda, MD 20892, (301) 806-7314, shahb@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group: Language and Communication Study Section.
Date: October 20-21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, 2121 P Street NW., Washington, DC 20037.
Contact Person: Wind Cowles, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3172, Bethesda, MD 20892,
cowleshw@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel: Ocular Surface, Cornea, and Refractive Error.
Date: October 20, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Pier 2620 Hotel, 2620 Jones Street, San Francisco, CA
94133.
Contact Person: Kristin Kramer, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5205, MSC 7846, Bethesda, MD
20892, (301) 437-0911, kramerkm@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 20-21, 2016.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC
20036.
Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3188, MSC 7808, Bethesda, MD 20892, 301-435-
1146, jig@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Virology--A Study Section.
Date: October 20-21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Alexandria, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD
20892, 301-496-6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurobiology of Epilepsy, Spinal Cord
Injury, and Protein, Processing in Neurodegeneration.
Date: October 20, 2016.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wei-Qin Zhao, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5181, MSC 7846, Bethesda, MD 20892-7846, 301-
435-1236, zhaow@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Child Psychopathology and Developmental
Disabilities Study Section.
Date: October 20-21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Jane A. Doussard-Roosevelt, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Pathogenic Eukaryotes Study Section.
Date: October 20-21, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Washington DC Downtown, 1199 Vermont Avenue
NW., Washington, DC 20005.
Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD
20892, 301-435-2306, boundst@csr.nih.gov.
[[Page 65364]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Drug Discovery and Mechanisms of Antimicrobial Resistance.
Date: October 20, 2016.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC
20036.
Contact Person: John C. Pugh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Language and Communication.
Date: October 20, 2016.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Palomar Hotel, 2121 P Street NW., Washington, DC 20037.
Contact Person: Maribeth Champoux, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7759, Bethesda, MD
20892, 301-594-3163, champoum@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 16, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-22815 Filed 9-21-16; 8:45 am]
BILLING CODE 4140-01-P
